相似文献
1
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR IMPROVES IMMUNOGENECITY OF HEPATITIS B VACCINE IN HEMODIALYSIS PATIENTS.
Med J Armed Forces India. 2000 Oct;56(4):296-297. doi: 10.1016/S0377-1237(17)30212-5. Epub 2017 Jun 12.
2
Effect of granulocyte macrophage colony stimulating factor on hepatitis-B vaccination in haemodialysis patients.
J Assoc Physicians India. 1999 Jun;47(6):602-4.
3
Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders.
Ren Fail. 2001 Sep;23(5):629-36. doi: 10.1081/jdi-100107359.
4
Granulocyte-macrophage colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients.
J Viral Hepat. 1999 Sep;6(5):405-9. doi: 10.1046/j.1365-2893.1999.00180.x.
5
Granulocyte macrophage colony stimulating factor augmented hepatitis B vaccine protocol for rapid seroprotection in voluntary kidney donors.
Indian J Med Res. 2004 Apr;119(4):162-4.
6
7
Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure--results of a prospective, randomized trial.
Ren Fail. 2003 Mar;25(2):255-66. doi: 10.1081/jdi-120018726.
8
Granulocyte-macrophage colony-stimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients.
Am J Nephrol. 2000 Jan-Feb;20(1):53-6. doi: 10.1159/000013556.
9
A randomized pilot trial on the effect of granulocyte-colony stimulating factor on antibody response in hemodialysis patients who had not responded to routine hepatitis B virus vaccine.
J Nephropathol. 2015 Jan;4(1):13-7. doi: 10.12860/jnp.2015.03. Epub 2015 Jan 1.
10
CD40 Ligand and GMCSF Coexpression Enhance the Immune Responses and Protective Efficacy of PCV2 Adenovirus Vaccine.
Viral Immunol. 2016 Apr;29(3):148-58. doi: 10.1089/vim.2015.0109. Epub 2016 Mar 16.
本文引用的文献
1
Effect of granulocyte macrophage colony stimulating factor on hepatitis-B vaccination in haemodialysis patients.
J Assoc Physicians India. 1999 Jun;47(6):602-4.
2
Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.
Nephron. 1995;70(4):397-401. doi: 10.1159/000188635.
3
Randomised placebo-controlled trial of hepatitis B surface antigen vaccine in french haemodialysis units: II, Haemodialysis patients.
Lancet. 1981 Apr 11;1(8224):797-800. doi: 10.1016/s0140-6736(81)92679-9.
4
Hepatitis B vaccine: immune responses in haemodialysis patients.
Lancet. 1980 Dec 6;2(8206):1211-3. doi: 10.1016/s0140-6736(80)92477-0.
5
Hepatitis B infection in a dialysis unit in South India.
J Assoc Physicians India. 1987 Apr;35(4):284-5.
6
7
Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients.
Am J Nephrol. 1992;12(3):144-7. doi: 10.1159/000168436.
Zotero 插件